Selection of blockbuster announcements

1. Li Auto Inc.: officially released the family's five flagship SUV- ideal L7

$Li Auto-W (02015.HK)$Announcement, on February 8, 2023, Li Auto Inc. officially released the family's five flagship SUV- ideal L7. With the release of the ideal L7 Air, the company also launched the ideal L8 Air at the same time to further enrich the product line. The ideal retail price of L7 Air, Pro and Max is 319800 yuan, 339800 yuan and 379800 yuan respectively. The ideal retail price of the L8 Air is RMB 339800. Delivery of ideal L7 Pro and ideal L7 Max will begin on March 1, 2023, and delivery of ideal L7 Air and ideal L8 Air will begin in early April 2023.

2. China Communications Construction: the newly signed contract value in 2022 is about 1.5 trillion yuan, an increase of 21.64% over the same period last year.

$CHINA COMM CONS (01800.HK)$It was announced that the newly signed contract in 2022 was about 1.5422 trillion yuan, an increase of 21.64 percent over the same period last year and 109 percent of the annual target. Of this total, infrastructure construction business, infrastructure design business, dredging business and other businesses were 1.36707 trillion yuan, 54.899 billion yuan, 106.654 billion yuan and 13.633 billion yuan respectively.

3. DongFeng Motor Group: January sales were about 108100, down 64.4% from the same period last year.

$DONGFENG GROUP (00489.HK)$It was announced that total car sales in January were 108100, down 64.4% from a year earlier. Of these, the production of new energy vehicles was 17100, down 19% from the same period last year; sales of new energy vehicles were 12100, down 38% from the same period last year; and Dongfeng, a subsidiary, sold 5468 vehicles, down 68.2% from the same period last year. Dongfeng Group, the parent company, sold 124600 vehicles, down 63.5% from the same period last year.

4. Aikang Medical: obtain the registration certificate of dental implant system three types of medical devices approved by the Drug Administration.

$Ak Medical (01789.HK)$The registration certificate of three types of medical devices for dental implant system approved by the State Drug Administration of China was published. In addition, the Group obtained the registration certificate of three types of medical devices for bone filling materials used in maxillofacial surgery in July 2022. The approval of the two products marks the group's official entry into the field of oral and maxillofacial repair.

5. Haohai Biotechnology: 140 million yuan will be transferred to Shenzhen's new industry, ophthalmology and new technology.

$HAOHAI BIOTEC (06826.HK)$It was announced that Haohai Pharmaceutical, a wholly-owned subsidiary of the company, plans to acquire 20% of the shares of Shenzhen New Industry Ophthalmology New Technology Co., Ltd., with a consideration of 140 million yuan. After the completion of the acquisition, the group will hold an 80% stake in the target company, which is mainly engaged in the sales of a number of imported ophthalmic products, such as intraocular lens, ophthalmic viscoelasticity, sodium hyaluronate gel for glaucoma surgery, and so on.

Financial data

CITIC (06030): net profit of Huaxia Fund in 2022 is 2.163 billion yuan.

Golden World Holdings (03918) changed from loss to profit of 107 million US dollars.

Shenzhen International (00152) expects annual profit attributable to shareholders to be about HK $900 million to HK $1.1 billion

Operation data

China Communications Construction (01800) the newly signed contract value of 1.542256 trillion yuan in 2022 increased by 21.64% over the same period last year.

DongFeng Motor Group (00489): January sales were about 108100, down 64.4% from the same period last year.

Fosun Tourism Culture (01992): Sanya Atlantis received a total of 474000 visitors during the Lunar New year holiday, an increase of 13.2% over the same period last year.

Contract sales of Hongyang Real Estate (01996) reached 1.109 billion yuan in January.

Baolong Real Estate (01238) January contract sales total 2.04 billion yuan

Merger and acquisition and sale

Cosco Group (03377) plans to acquire all the shares of Shandong Detianjia Real Estate by 1.584 billion yuan.

Haohai Biotechnology (06826) plans to transfer 20% equity of Shenzhen's new industry and new ophthalmology technology for 140 million yuan.

Investment and operation

Li Auto Inc.-W (02015) officially released the family's five flagship SUV- ideal L7, ideal L7 Air and ideal L8 Air will begin delivery in early April

Yabo Technology Holdings (08279) entered into strategic cooperation agreements with Galaxy ICC, Variety Hall, Beijing Barley Culture Media and BABA Film Group.

Yitai Coal (03948) suspends the construction of 1 million t / a coal-to-oil demonstration project in Yili

Broad Pharmaceuticals (00512): phase Ib clinical trials of global innovative product STC3141 in Australia and Belgium for the treatment of sepsis have been completed for all patients.

China Everbright Water (01857) Joint Venture Jinan Light Water sewage treatment has been set up in China.

Aikang Medical (01789) obtained the registration certificate of three types of medical devices in dental implant system approved by FDA.

Pay dividends and interest

Cathay Pacific (00293): deferred dividend payment of preferred shares

Repurchase cancellation

AIA Group Limited (01299) spent HK $225 million to buy back 2.6216 million shares on Feb. 8.

Hisense Home Appliances (00921) spent 15.7413 million yuan to buy back 931400 A shares on Feb. 8.

Yum China (09987) spent US $1 million to buy back 16600 shares on Feb. 7.

ESR Cayman Limited (01821) spent HK $5.46 million to buy back 350000 shares on Feb. 8.

Sunshine Paper (02002) spent HK $2.973 million to buy back 1.394 million shares on February 8th

Edit / Somer